Stay updated on AK002 for Eosinophilic Gastritis Clinical Trial

Sign up to get notified when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK002 for Eosinophilic Gastritis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T13:16:22.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Site updates include the addition of Revision: v3.4.2, and the previously displayed notices (lapse in government funding) and Revision: v3.4.1 were removed as routine maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T01:36:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with NIH Clinical Center status and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:18:24.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and minor wording changes to QC criteria labels and No FEAR Act Data, along with a new site revision indicator 'v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-27T20:56:56.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.3.4) and removal of the previous revision (v3.3.3). This is a metadata update and does not modify study data, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2026-01-13T17:42:52.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating states (AL, AZ, AR, CA, CO, CT, FL, GA, IL, LA, MD, MA, MI, MN, MO, NV, NY, NC, OH, OK, PA, TN, TX, UT, VA, WA) and Revision: v3.3.3. Removed the previous per-state Location subsections and the HHS Vulnerability Disclosure link.
    Difference
    2%
    Check dated 2025-12-23T08:32:05.000Z thumbnail image

Stay in the know with updates to AK002 for Eosinophilic Gastritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.